DNAstack
DNAstack's Omics AI platform empowers data custodians to securely connect, protect, and share their data, enabling researchers to discover, access, and analyze it using AI-powered tools.
Products
DNAstack offers a flagship product suite called Omics AI, which provides data custodians with the capabilities to connect, protect, and share their data. Omics AI simplifies the process for researchers to discover, access, and analyze data using AI-driven tools. The suite incorporates tools such as Publisher, Explorer, Workbench, and Passport. These tools facilitate data integration, networking, analysis, and access. Omics AI supports federated data networks across various cloud platforms including Microsoft Azure, Amazon Web Services, and Google Cloud.
Compliance and Standards
DNAstack's products are designed with a focus on security and privacy, adhering to international standards and regulations such as GDPR, HIPAA, and PIPEDA. The company implements open standards from the Global Alliance for Genomics & Health (GA4GH) and internationally recognized standards bodies. This compliance ensures that users can confidently manage and share data within the guidelines of global privacy regulations.
Sectors and Use Cases
DNAstack's Omics AI platform is utilized by a diverse array of sectors including pharmaceutical companies, hospitals, universities, patient advocacy groups, funders, sequencing facilities, government agencies, and consortiums. Specific applications of the platform include powering the MSSNG database, the world's largest autism whole-genome dataset, and the Target ALS Data Platform, which supports ALS research. The platform also supports the Canadian COVID-19 Genomics Network (CanCOGeN) VirusSeq initiative and the Canadian Platform for Genomics & Precision Health (CP4GPH), a $14.5 million initiative facilitating AI-driven insights across genomics and health data networks.
Partnerships and Collaborations
DNAstack collaborates with various institutions to advance AI innovation in genomics and precision health. They have partnered with the Vector Institute to propel AI developments within Canada. The company's Omics AI platform has been integral in several large-scale initiatives, such as the Autism Sharing Initiative, a global network for sharing genomics and clinical data to enhance autism research. DNAstack's platform has also significantly contributed to pandemic surveillance through the Viral AI network, processing and sharing 1.6 million SARS-CoV-2 genomes.
Awards and Recognitions
DNAstack has received notable accolades, including the Technology Pioneer Award from the World Economic Forum. This award was given in recognition of DNAstack's contributions to establishing federated data networks and generating significant insights in areas such as pandemic surveillance, neuroscience, rare diseases, and oncology. These recognitions underscore DNAstack's commitment to advancing technologies in genomics and health data management.